Institute of BioMedical Research Corp. (MRES)
0.0015
0.00 (0.00%)
USD |
OTCM |
Nov 03, 16:00
Institute of BioMedical Research Enterprise Value : 4.332M for Nov. 3, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 4.332M |
| November 02, 2026 | 4.332M |
| October 30, 2026 | 4.620M |
| October 29, 2026 | 4.620M |
| October 28, 2026 | 4.620M |
| October 27, 2026 | 4.620M |
| October 26, 2026 | 4.332M |
| October 23, 2026 | 4.505M |
| October 22, 2026 | 3.755M |
| October 21, 2026 | 6.062M |
| October 20, 2026 | 5.774M |
| October 19, 2026 | 5.552M |
| October 16, 2026 | 5.774M |
| October 15, 2026 | 5.486M |
| October 14, 2026 | 5.486M |
| October 13, 2026 | 5.197M |
| October 12, 2026 | 5.197M |
| October 09, 2026 | 5.197M |
| October 08, 2026 | 4.909M |
| October 07, 2026 | 4.909M |
| October 06, 2026 | 4.909M |
| October 05, 2026 | 5.774M |
| October 02, 2026 | 5.053M |
| October 01, 2026 | 5.918M |
| September 30, 2026 | 5.918M |
| Date | Value |
|---|---|
| September 29, 2026 | 5.774M |
| September 28, 2026 | 5.774M |
| September 25, 2026 | 6.351M |
| September 24, 2026 | 6.351M |
| September 23, 2026 | 6.351M |
| September 22, 2026 | 6.351M |
| September 21, 2026 | 5.774M |
| September 18, 2026 | 5.774M |
| September 17, 2026 | 5.341M |
| September 16, 2026 | 7.735M |
| September 15, 2026 | 7.735M |
| September 14, 2026 | 8.370M |
| September 11, 2026 | 8.370M |
| September 10, 2026 | 7.793M |
| September 09, 2026 | 9.523M |
| September 08, 2026 | 10.68M |
| September 04, 2026 | 8.641M |
| September 03, 2026 | 9.812M |
| September 02, 2026 | 11.54M |
| September 01, 2026 | 11.54M |
| August 31, 2026 | 11.54M |
| August 28, 2026 | 11.25M |
| August 27, 2026 | 8.946M |
| August 26, 2026 | 5.197M |
| August 25, 2026 | 5.197M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 10.73M |
| Cavitation Technologies, Inc. | 10.77M |
| Clene, Inc. | 60.85M |
| Bon Natural Life Ltd. | -- |
| Biohaven Ltd. | 2.497B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0515M |
| Revenue (Quarterly) | 0.025M |
| Total Expenses (Quarterly) | 0.0436M |
| Profit Margin (Quarterly) | -206.0% |
| Earnings Yield | -20.00% |
| Normalized Earnings Yield | 26.67 |